Development of a DNA damage assay system using stable human hepatocytes

Area of Science:

• Toxicology
• Genetics
• Biochemistry

Background:

• Species differences in metabolism pose challenges for toxicological studies.
• Human metabolic systems are highly variable, limiting standardized in vitro genotoxicity testing.
• There is a need for genotoxicity assays that better mimic human physiology.

Purpose of the Study:

• To develop and validate an in-cell ELISA system for measuring DNA damage in stable human hepatocytes.
• To assess the utility of the γH2AX marker in human hepatocytes for genotoxicity evaluation.
• To establish optimal assay conditions for detecting genotoxic responses in a human-relevant system.

Main Methods:

• Development of an in-cell ELISA measuring γH2AX (DNA damage marker) in stable human hepatocytes (HepaSH cells).
• HepaSH cells stably express metabolic enzymes and drug transporters, mimicking human physiology.
• Exposure of HepaSH cells to known indirect mutagens (e.g., benzo(a)pyrene) to assess dose-dependent DNA damage.

Main Results:

• The developed γH2AX-SHE assay successfully detected dose-dependent increases in DNA damage in response to indirect mutagens.
• A treatment duration of 16 hours or longer was required for genotoxic response detection.
• High cytotoxicity (48-hour exposure) could interfere with accurate γH2AX quantification.

Conclusions:

• The γH2AX-SHE assay is a valuable tool for detecting DNA damage in a human-relevant metabolic context.
• Recommended assay conditions include a 24-hour treatment period and DMSO concentration ≤1%.
• Responses at highly cytotoxic doses (<60% cell survival) require careful interpretation due to potential lack of biological relevance.